| pubmed-article:16782927 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16782927 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:16782927 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:16782927 | lifeskim:mentions | umls-concept:C0206624 | lld:lifeskim |
| pubmed-article:16782927 | lifeskim:mentions | umls-concept:C0032207 | lld:lifeskim |
| pubmed-article:16782927 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:16782927 | lifeskim:mentions | umls-concept:C0679199 | lld:lifeskim |
| pubmed-article:16782927 | lifeskim:mentions | umls-concept:C1521725 | lld:lifeskim |
| pubmed-article:16782927 | lifeskim:mentions | umls-concept:C1272745 | lld:lifeskim |
| pubmed-article:16782927 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:16782927 | pubmed:issue | 18 | lld:pubmed |
| pubmed-article:16782927 | pubmed:dateCreated | 2006-6-19 | lld:pubmed |
| pubmed-article:16782927 | pubmed:abstractText | The INT-0098 Intergroup Liver Tumor Study demonstrated no statistically significant differences in event-free and overall survival between patients randomized to treatment with either cisplatin + fluorouracil + vincristine (C5V) or cisplatin + doxorubicin. Results from this and other therapeutic trials suggested that cisplatin was the most active agent against hepatoblastoma. To increase the platinum dose-intensity, a novel regimen was developed alternating carboplatin and cisplatin (CC) every 2 weeks. The P9645 study was designed to compare the risk of treatment failure for patients with stage III/IV hepatoblastoma randomized to either C5V or CC. | lld:pubmed |
| pubmed-article:16782927 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16782927 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16782927 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16782927 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16782927 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16782927 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16782927 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16782927 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16782927 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16782927 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:16782927 | pubmed:issn | 1527-7755 | lld:pubmed |
| pubmed-article:16782927 | pubmed:author | pubmed-author:NewmanKurtK | lld:pubmed |
| pubmed-article:16782927 | pubmed:author | pubmed-author:FinegoldMilto... | lld:pubmed |
| pubmed-article:16782927 | pubmed:author | pubmed-author:BowmanLauraL | lld:pubmed |
| pubmed-article:16782927 | pubmed:author | pubmed-author:ReynoldsMarle... | lld:pubmed |
| pubmed-article:16782927 | pubmed:author | pubmed-author:KrailoMark... | lld:pubmed |
| pubmed-article:16782927 | pubmed:author | pubmed-author:MalogolowkinM... | lld:pubmed |
| pubmed-article:16782927 | pubmed:author | pubmed-author:CastleberryRo... | lld:pubmed |
| pubmed-article:16782927 | pubmed:author | pubmed-author:LondonWendy... | lld:pubmed |
| pubmed-article:16782927 | pubmed:author | pubmed-author:WomerRichard... | lld:pubmed |
| pubmed-article:16782927 | pubmed:author | pubmed-author:KatzensteinHo... | lld:pubmed |
| pubmed-article:16782927 | pubmed:author | pubmed-author:GreffeBrianB | lld:pubmed |
| pubmed-article:16782927 | pubmed:author | pubmed-author:ChenZhengjiaZ | lld:pubmed |
| pubmed-article:16782927 | pubmed:author | pubmed-author:RowlandJonJ | lld:pubmed |
| pubmed-article:16782927 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:16782927 | pubmed:day | 20 | lld:pubmed |
| pubmed-article:16782927 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:16782927 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16782927 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16782927 | pubmed:pagination | 2879-84 | lld:pubmed |
| pubmed-article:16782927 | pubmed:meshHeading | pubmed-meshheading:16782927... | lld:pubmed |
| pubmed-article:16782927 | pubmed:meshHeading | pubmed-meshheading:16782927... | lld:pubmed |
| pubmed-article:16782927 | pubmed:meshHeading | pubmed-meshheading:16782927... | lld:pubmed |
| pubmed-article:16782927 | pubmed:meshHeading | pubmed-meshheading:16782927... | lld:pubmed |
| pubmed-article:16782927 | pubmed:meshHeading | pubmed-meshheading:16782927... | lld:pubmed |
| pubmed-article:16782927 | pubmed:meshHeading | pubmed-meshheading:16782927... | lld:pubmed |
| pubmed-article:16782927 | pubmed:meshHeading | pubmed-meshheading:16782927... | lld:pubmed |
| pubmed-article:16782927 | pubmed:meshHeading | pubmed-meshheading:16782927... | lld:pubmed |
| pubmed-article:16782927 | pubmed:meshHeading | pubmed-meshheading:16782927... | lld:pubmed |
| pubmed-article:16782927 | pubmed:meshHeading | pubmed-meshheading:16782927... | lld:pubmed |
| pubmed-article:16782927 | pubmed:meshHeading | pubmed-meshheading:16782927... | lld:pubmed |
| pubmed-article:16782927 | pubmed:meshHeading | pubmed-meshheading:16782927... | lld:pubmed |
| pubmed-article:16782927 | pubmed:meshHeading | pubmed-meshheading:16782927... | lld:pubmed |
| pubmed-article:16782927 | pubmed:meshHeading | pubmed-meshheading:16782927... | lld:pubmed |
| pubmed-article:16782927 | pubmed:meshHeading | pubmed-meshheading:16782927... | lld:pubmed |
| pubmed-article:16782927 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16782927 | pubmed:articleTitle | Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma. | lld:pubmed |
| pubmed-article:16782927 | pubmed:affiliation | Childrens Hospital Los Angeles, Division of Hematology-Oncology, Los Angeles, CA 90027, USA. mmalogolowkin@chla.usc.edu | lld:pubmed |
| pubmed-article:16782927 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16782927 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16782927 | lld:pubmed |
